Raisa Chowdhury, Jennifer A Silver, Eleni Philippopoulos, Karen M Kost
{"title":"Pitch Alteration Techniques for Transgender Women: A Systematic Review of Surgical and Nonsurgical Approaches.","authors":"Raisa Chowdhury, Jennifer A Silver, Eleni Philippopoulos, Karen M Kost","doi":"10.1016/j.jvoice.2025.06.032","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To systematically evaluate and compare the effectiveness of surgical and nonsurgical pitch elevation techniques in transgender women using acoustic outcomes and validated patient-reported outcome measures (PROMs).</p><p><strong>Methods: </strong>A systematic review was conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Comprehensive searches of Ovid MEDLINE, Embase, CENTRAL, PsycINFO, CINAHL, and gray literature were completed through January 2025. Included studies involved transgender women (≥18 years) undergoing pitch elevation via surgical (Wendler glottoplasty [WG], cricothyroid approximation [CTA], vocal fold shortening and retrodisplacement of the anterior commissure [VFSRAC], and laser-assisted voice adjustment [LAVA]), laser-reduction glottoplasty [LRG], nonsurgical (voice therapy [VT]), or combination approaches. Eligible studies reported both changes in fundamental frequency (F0) and validated PROMs, such as the Voice Handicap Index (VHI) or Trans Woman Voice Questionnaire (TWVQ). Risk of bias was assessed using the Cochrane Risk of Bias Tool and Newcastle-Ottawa Scale. Data were synthesized narratively with weighted means calculated for key outcomes.</p><p><strong>Results: </strong>Twenty-two studies (N = 977) were included. VFSRAC yielded the highest mean F0 increase (+73.3 Hz), followed by WG (+54.1 Hz), VT (+39.9 Hz), CTA (+30.3 Hz), and LAVA (+26 Hz). WG + VT showed comparable F0 gains (+54.5 Hz) with more consistent outcomes. TWVQ scores improved most with WG + VT (-47.9), followed by WG (-29.0) and VT (-18.7). VHI scores improved most with LAVA (-48.0) and WG (-21.7); VFSRAC and CTA showed modest PROM improvements. Adverse events, including granuloma and vocal fatigue, were more common with surgical combinations. Follow-up ranged from 2 weeks to 4.4 years, with most studies reporting 6-12 months.</p><p><strong>Conclusion: </strong>Surgical and nonsurgical interventions both elevate pitch and improve voice-related quality of life. Surgery provides greater F0 gains, while combining VT enhances patient satisfaction. Findings support individualized care and the need for standardized PROMs in future studies.</p>","PeriodicalId":49954,"journal":{"name":"Journal of Voice","volume":" ","pages":""},"PeriodicalIF":2.5000,"publicationDate":"2025-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Voice","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jvoice.2025.06.032","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"AUDIOLOGY & SPEECH-LANGUAGE PATHOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: To systematically evaluate and compare the effectiveness of surgical and nonsurgical pitch elevation techniques in transgender women using acoustic outcomes and validated patient-reported outcome measures (PROMs).
Methods: A systematic review was conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Comprehensive searches of Ovid MEDLINE, Embase, CENTRAL, PsycINFO, CINAHL, and gray literature were completed through January 2025. Included studies involved transgender women (≥18 years) undergoing pitch elevation via surgical (Wendler glottoplasty [WG], cricothyroid approximation [CTA], vocal fold shortening and retrodisplacement of the anterior commissure [VFSRAC], and laser-assisted voice adjustment [LAVA]), laser-reduction glottoplasty [LRG], nonsurgical (voice therapy [VT]), or combination approaches. Eligible studies reported both changes in fundamental frequency (F0) and validated PROMs, such as the Voice Handicap Index (VHI) or Trans Woman Voice Questionnaire (TWVQ). Risk of bias was assessed using the Cochrane Risk of Bias Tool and Newcastle-Ottawa Scale. Data were synthesized narratively with weighted means calculated for key outcomes.
Results: Twenty-two studies (N = 977) were included. VFSRAC yielded the highest mean F0 increase (+73.3 Hz), followed by WG (+54.1 Hz), VT (+39.9 Hz), CTA (+30.3 Hz), and LAVA (+26 Hz). WG + VT showed comparable F0 gains (+54.5 Hz) with more consistent outcomes. TWVQ scores improved most with WG + VT (-47.9), followed by WG (-29.0) and VT (-18.7). VHI scores improved most with LAVA (-48.0) and WG (-21.7); VFSRAC and CTA showed modest PROM improvements. Adverse events, including granuloma and vocal fatigue, were more common with surgical combinations. Follow-up ranged from 2 weeks to 4.4 years, with most studies reporting 6-12 months.
Conclusion: Surgical and nonsurgical interventions both elevate pitch and improve voice-related quality of life. Surgery provides greater F0 gains, while combining VT enhances patient satisfaction. Findings support individualized care and the need for standardized PROMs in future studies.
期刊介绍:
The Journal of Voice is widely regarded as the world''s premiere journal for voice medicine and research. This peer-reviewed publication is listed in Index Medicus and is indexed by the Institute for Scientific Information. The journal contains articles written by experts throughout the world on all topics in voice sciences, voice medicine and surgery, and speech-language pathologists'' management of voice-related problems. The journal includes clinical articles, clinical research, and laboratory research. Members of the Foundation receive the journal as a benefit of membership.